Prof. Doron Gerber – An Integrated Microfluidics Approach for Personalized Cancer Drug Sensitivity and Resistance Assay

Abstract Cancer is the second leading cause of death globally. Matching proper treatment and dosage is crucial for a positive outcome. Any given drug may affect patients with similar tumors differently. Personalized medicine aims to address this issue. Unfortunately, most cancer samples cannot be expanded in culture, limiting conventional cell‐based testing. Herein, presented is a…

Read More